XERI — what changed in the latest 10-Q
A section-by-section comparison of XERI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-15 vs the prior 10-Q · 2026-02-17
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +6 | −6 | ~17 | 11 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | Text added/removed | 0 | 0 | ~2 | 2 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-15
Total consulting and advisory expenses were $276,450 and $266,720 for the nine months ended March 31, 2026 and 2025, respectively, an increase of $9,730. The increase was primarily related to an increase in advisory board fees in the amount of $84,621 relating to timing of board member anniversary d…
Total related party consulting fees were $235,000 and $364,500 for the nine months ended March 31, 2026 and 2025, respectively, a decrease of $129,500. In the current period, the Company had reduced funds to pay consulting fees and the related parties agreed to accept reduced amounts of compensation…
Total consulting and advisory expenses were $170,500 and $141,600 for the three months ended March 31, 2026 and 2025, respectively, an increase of $28,900. The increase was primarily related to an increase in advisory board fees in the amount of $28,900 relating to timing of board member anniversary…
Total related party consulting fees were $72,000 and $113,500 for the three months ended March 31, 2026 and 2025, respectively, a decrease of $41,500. In the current period, the Company had reduced funds to pay consulting fees and the related parties agreed to accept reduced amounts.
Total research and development expenses were $29,636 and $30,224 for the three months ended March 31, 2026, and 2025, respectively, a decrease of $588 which was insignificant.
Text removed vs the prior filing · source: 10-Q · 2026-02-17
Total consulting and advisory expenses were $105,950 and $125,120 for the six months ended December 31, 2025 and 2024, respectively, a decrease of $19,170. The decrease was primarily related to non-recurring consulting fees during the quarter ended December 31, 2024. Additionally, there was a small …
Total related party consulting fees were $163,000 and $251,000 for the six months ended December 31, 2025 and 2024, respectively, a decrease of $88,000. In addition to the consulting agreement amounts, the Company will pay additional consulting fees to related parties when the Company has increased …
Total consulting and advisory expenses were $38,750 and $36,137 for the three months ended December 31, 2025 and 2024, respectively, an increase of $2,613. The increase was insignificant.
Total related party consulting fees were $89,000 and $128,000 for the three months ended December 31, 2025 and 2024, respectively, a decrease of $39,000. In addition to the consulting agreement amounts, the Company will pay additional consulting fees to related parties when the Company has increased…
Total research and development expenses were $16,303 and $15 for the three months ended December 31, 2025, and 2024, respectively, an increase of $16,288. The primary reason for the increase was increased research and development expenses related to testing and initial product development schedule i…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice